In conclusion, aberrant EZH2 activity is also emerging as an important player in cancer because, besides contributing to repress the transcription of several tumor suppressor genes, it is interconnected with several oncogenic molecules that regulate and can be regulated by this methyltransferase, both in a methylation-dependent or independent fashion (Figure 7). This evidence concerns the gene EZH2 and neoplasm.